- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Neurofibromatosis Type 2 in Switzerland
Total 1155 results
-
AstraZenecaRecruitingNeurofibromatosis Type 1Portugal, Spain, United Kingdom, Israel, France, Italy, Switzerland, Germany, Austria
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
University of ZurichUnknownPrediabetes / Type 2 DiabetesSwitzerland
-
Cytos Biotechnology AGCompletedType 2 Diabetes MellitusGermany, Switzerland
-
Cabinet MedicalTrialance SCCLCompletedType 2 Diabetes Mellitus | Overweight and ObesitySwitzerland
-
Janssen Research & Development, LLCCompleted
-
University Hospital, Basel, SwitzerlandUniversity of Basel; Solothurner Spitäler AGCompletedDiabetes Mellitus Type 2Switzerland
-
University Hospital, Basel, SwitzerlandSolidarMed; Swiss Agency for Development and Cooperation (SDC); World Diabetes...RecruitingType 2 Diabetes Mellitus (T2D)Lesotho, Switzerland
-
University Hospital, GenevaMaastricht University Medical Center; Swiss Federal Institute of Technology; Ecole...Completed
-
XOMA (US) LLCCompleted
-
Carole ClairTerminatedSmoking Cessation | Diabetes Type 2Switzerland
-
University Hospital, Basel, SwitzerlandRecruitingInflammation | Metabolic Disease | Diabetes Mellitus Type 2 in Obese | Glucose Metabolism Disorders (Including Diabetes Mellitus)Switzerland
-
Kantonsspital Baselland BruderholzCompletedDiabetes Mellitus Type 2Switzerland
-
University of ZurichCompletedType 2 DiabetesSwitzerland
-
University Hospital, Basel, SwitzerlandUniversity Hospital Schleswig-HolsteinCompletedType 2 Diabetes Mellitus | Bone FracturesSwitzerland
-
University of ZurichSteno Diabetes Center CopenhagenCompletedType 2 DiabetesSwitzerland, Denmark
-
University Hospital, Basel, SwitzerlandMcGill UniversityCompletedInsulin Resistance | Diabetes Mellitus Type 2 | Other Functional Disturbances Following Cardiac SurgerySwitzerland
-
Medical University of ViennaMedical University of Graz; Charite University, Berlin, Germany; Hannover Medical... and other collaboratorsCompletedSarcoma | Hematologic Diseases | Leukemia | Brain Tumor | Neurofibromatoses | NeuroblastomaAustria, Germany, Switzerland, Italy
-
Marc Y.DonathCompletedType 2 DiabetesSwitzerland
-
University Children's Hospital, ZurichCompletedRadius Fractures | Forearm Fracture | Salter-Harris Type I | Salter-Harris Type 2Switzerland
-
University Hospital, Basel, SwitzerlandOlatec Therapeutics LLC; State Secretariat for Education Research and Innovation... and other collaboratorsNot yet recruitingDiabetes Mellitus, Type 2Switzerland
-
University Hospital TuebingenMedical University of Vienna; University of Bern; CenTrial GmbHTerminatedObesity | DiabetesAustria, Germany, Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedEfficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 DiabetesDiabetes Mellitus, Type 2Switzerland
-
NovartisCompletedDiabetes Mellitus, Type 2Switzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland
-
University Hospital Inselspital, BerneUniversity of Bern; Lucerne University of Applied Sciences and ArtsCompleted
-
NovartisCompletedDiabetes Mellitus, Type 2Switzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Switzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSwitzerland
-
University of CambridgeUniversity Hospital Inselspital, BerneCompletedEnd Stage Renal Disease | Type 2 DiabetesUnited Kingdom, Switzerland
-
University of ZurichEuropean Foundation for the Study of DiabetesCompleted
-
University Hospital Inselspital, BerneTerminatedDiabetes Mellitus, Type 2Switzerland
-
Berner Klinik MontanaCompleted
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
QualiCCareNovo Nordisk A/S; Sanofi; Swiss Society of Endocrinology and Diabetology; Roche... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Primary CareSwitzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Switzerland, Germany
-
University of BaselSwiss National Science FoundationCompletedObesity | Diabetes Mellitus, Type 2 | OverweightSwitzerland
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Germany, Switzerland
-
Cantonal Hospital of St. GallenMedical University of Graz; European Foundation for the Study of DiabetesCompletedDiabetes Mellitus, Type 2 | Bariatric Surgery CandidateAustria, Switzerland
-
Centre Hospitalier Universitaire VaudoisCompletedSARS-CoV-2Switzerland
-
Center for Primary Care and Public Health (Unisante)...pharmaSuisse; santésuisse; CurafuturaCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, ChronicSwitzerland
-
Sintetica SACross S.A.CompletedPhase 1: Pain Management | Phase 2: Pain ManagementSwitzerland
-
University Hospital, GenevaUniversity of Geneva, SwitzerlandCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Germany, United Kingdom, Sweden, Switzerland
-
University Hospital, Basel, SwitzerlandCompletedSevere-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)Switzerland